PBMI Specialty Rx Forum | Program
7:00 am | Registration Opens (breakfast on your own)
8:30 am to 9:30 am
Evolution of the Specialty Pharmacy Landscape and Beyond
William Roth, Founding Partner and President, Blue Fin Group
In this session, the speaker will discuss how the changes in product mix coupled with the use of old spend management tools are serving as a barrier to new science, care and cost management.
9:30 am to 10:30 am
Challenges Employers Face (Employer Roundtable)
Laura Bercier, Global Benefits Strategy, Boeing, Tina Hayes, HR Principal, Duke Energy, and Kembre Roberts, Manager of Wellness, Southwest Airlines
In this roundtable discussion, attendees will get an insider’s perspective from three large employers who will share their experiences, challenges, and unique strategies they’ve used to rein in the specialty drug benefit costs.
10:30 am to 10:45 am | Morning Break
10:45 am to 11:45 am
Navigating the Complexity of Cancer
Sumit Dutta, MD, Sr. Vice President and Chief Medical Officer, OptumRx
Learn about strategies regarding site of service optimization and member engagement to improve care while significantly lowering medical costs. See the latest outcomes from new studies today and what will impact this space tomorrow.
11:45 am to 1:00 pm | Lunch
1:00 pm to 2:00 pm
Specialty Outlook: Pharma Perspective – AbbVie (Speaker TBD)
During this session, attendees will hear what lies ahead in the face of specialty from a specialty drug manufacturer perspective.
2:00 pm to 3:00 pm
Specialty Outlook: Specialty Pharmacy Perspective
Don Vidic RPh MBA, Chief Pharmacy and Growth Officer, AllianceRx Walgreens Prime
During this session, attendees will hear unique professional perspectives on the current state and future direction of the industry from a specialty pharmacy perspective.
3:00 pm to 3:15 pm | Afternoon Break
3:15 pm to 4:15 pm
Value-Based Pharmacy Management
Surya Singh, MD, Corporate Vice President & Chief Medical Officer, Specialty, CVS Health
In other consumer goods industries, consumers do not routinely pay for something that does not work or is only partially effective. In healthcare, however, this has not historically been the norm. However, we are increasingly seeing a movement toward value-based healthcare and away from fee-for-service reimbursement models. This is evidenced by greater emphasis on alternative payment models, including Accountable Care Organizations (ACOs), which incentivize high-quality care and better patient outcomes. In the realm of pharmacy, new models are emerging that tie reimbursement for a drug to the value delivered, not volume or a pre-set price. In this session, we will provide an overview of the emerging value-based pharmacy management models that aim to improve health outcomes and lower costs.
4:15 pm to 4:30 pm | Closing Remarks